Your browser doesn't support javascript.
loading
Semaphorin3A Exacerbates Cardiac Microvascular Rarefaction in Pressure Overload-Induced Heart Disease.
Li, Chaofu; Zhao, Yongchao; Li, Fuhai; Wang, Zimu; Qiu, Zhimei; Yang, Yukun; Xiong, Weidong; Wang, Rui; Chen, Han; Xu, Fei; Zang, Tongtong; Pei, Zhiqiang; Wang, Yan; Shi, Bei; Shen, Li; Ge, Junbo.
Affiliation
  • Li C; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Xuhui District, Shanghai, 20032, P. R. China.
  • Zhao Y; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Xuhui District, Shanghai, 20032, P. R. China.
  • Li F; Department of Cardiology, Affiliated Hospital of Qingdao University, Qingdao, 266000, P. R. China.
  • Wang Z; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Xuhui District, Shanghai, 20032, P. R. China.
  • Qiu Z; Department of Cardiology, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, P. R. China.
  • Yang Y; The neuroscience lab, University Hospital Essen, University of Duisburg-Essen, D-45122, Essen, Germany.
  • Xiong W; Department of Cardiology, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, P. R. China.
  • Wang R; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Xuhui District, Shanghai, 20032, P. R. China.
  • Chen H; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Xuhui District, Shanghai, 20032, P. R. China.
  • Xu F; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Xuhui District, Shanghai, 20032, P. R. China.
  • Zang T; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Xuhui District, Shanghai, 20032, P. R. China.
  • Pei Z; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Xuhui District, Shanghai, 20032, P. R. China.
  • Wang Y; Department of Cardiology, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, P. R. China.
  • Shi B; Department of Cardiology, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, P. R. China.
  • Shen L; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Xuhui District, Shanghai, 20032, P. R. China.
  • Ge J; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Xuhui District, Shanghai, 20032, P. R. China.
Adv Sci (Weinh) ; 10(21): e2206801, 2023 07.
Article in En | MEDLINE | ID: mdl-37310417
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Microvascular Rarefaction / Heart Diseases Type of study: Prognostic_studies Limits: Animals Language: En Journal: Adv Sci (Weinh) Year: 2023 Document type: Article Country of publication: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Microvascular Rarefaction / Heart Diseases Type of study: Prognostic_studies Limits: Animals Language: En Journal: Adv Sci (Weinh) Year: 2023 Document type: Article Country of publication: Alemania